Research Institute for Biological Safety Problems   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Gvardeyskiy Kazakhstan (1958)

Organization Overview

First Clinical Trial
2013
NCT02501421
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Research Institute for Biological Safety Problems